Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Dec. 15, 1998

La Jolla presents promising primate data on new xenotransplantation Toleragen candidate

Dec. 14, 1998

OraVax and Pasteur Merieux Connaught codevelop dengue fever vaccine

Dec. 14, 1998

Ariad initiates phase I trial with AP-1903 for treatment of GVHD

Dec. 11, 1998

Strategic alliance formed with SB for intranasal flu vaccine in development at BioChem Pharma

Dec. 11, 1998

Status of FluMist influenza vaccine updated by Aviron

Dec. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...